Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Drug Pricing Hearing Looms As Unparalleled Event For Pharma

Executive Summary

From Vioxx to EpiPen, industry has been called in to testify before Congress on a range of issues. But with seven big pharma leaders having accepted the Senate Finance Committee's invitation Feb. 26, the stage is set for some exceptional political theater.
Advertisement

Related Content

Drug Pricing And The Trump Effect: How To Make A High Profile Hearing Vanish
Big Pharma Defuses Drug Pricing Landmines On Capitol Hill
Big Pharma Defuses Drug Pricing Landmines On Capitol Hill
A Tale Of Two Committees: Which Probed EpiPen Better?
EpiPen Price Hearing: House Plays Bootleg Tape Of Shkreli Event
It Was Shkreli's Show, But Pharma Was On Trial
Tone Deaf: FDA Commissioner Hits the Wrong Note
Sen. Baucus Urges More Comparative Research At Vioxx Hearing

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel